FDA Approved: SAJAZIR — Original Application (Cycle Pharmaceuticals Ltd-Uk)

View source ↗

Summary

FDA approved SAJAZIR (icatibant) under an original ANDA from Cycle Pharmaceuticals Ltd-Uk, establishing a generic icatibant option for treating acute hereditary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• SAJAZIR (icatibant)

Snippet

ORIG AP for SAJAZIR (ICATIBANT)